Browse by category

Shimadzu Medical Systems USA has launched the FLUOROspeed X1 edition ST, patient side conventional RF table system with a 665lb static patient weight capacity (500lb all motion weight capacity), for both bariatric and routine daily fluoroscopic and radiographic exams. According to the company, the X1 offers a cost-effective balance of functionality to support a wide range of general RF applications, such as chest, abdomen, or extremities along with Upper GI's, modified swallo

The first commercial EndoZip Automated Suturing System for Endoscopic Sleeve Gastroplasty (ESG) cases have been performed in France. The cases were performed at the Institute of Image-Guided Surgery (IHU Strasbourg) in Strasbourg, France, under the leadership of Professor Silvana Perretta, Chief of Foregut Surgery and Advanced Gastrointestinal Endoscopy. This milestone represents another important step in Nitinotes' European commercial expansion following recent introductions

GT Metabolic Solutions has received CE certification (CE Mark) under the EU Medical Device Regulation (EU MDR) that enables commercialisation of the GT Metabolic Magnet System across the European Economic Area (EEA). GT Metabolic achieved successful review and certification of the GT Metabolic Magnet System for side-to-side enteroenterostomy (40mm, 50mm Magnets; throughout the small bowel) and gastroenterostomy (60mm, 70mm Magnets; stomach to small bowel), the first integrate

Medtronic has announced significant milestones to unlock expanded indications for the Hugo robotic-assisted surgery (RAS) system in the US. The company has submitted 510(k) clearance for gynaecological surgery, general surgery indication including hernia repair, the LigaSure RAS Maryland instrument and for the ProGrip Advanced mesh for use in robotic-assisted ventral hernia repair. These milestones build momentum for Medtronic's Surgical business and its purposeful launch of

Novo Nordisk has announced that the Committee for Medicinal Products for Human Use (CHMP) under the European Medicines Agency (EMA) has adopted a positive opinion, recommending marketing authorisation of Wegovy 7.2 mg (once-weekly injectable semaglutide 7.2 mg) in a single-dose pen and Wegovy pill. Wegovy 7.2 mg is already available in the EU for adults with obesity, dosed as three injections of 2.4 mg, and is based on results from the STEP UP trial programme. In the STEP UP

More than one billion people worldwide are living with obesity. Lifestyle intervention programmes, GLP-1 medications and bariatric surgery can be transformative, but they do not exist in a nutritional vacuum. Deficiencies are common among people affected by obesity before treatment begins, and surgery or medication can make them harder to ignore. Patients arrive underprepared, find little nutritional support built into their care, and are largely left to manage the consequenc

Olympus Corporation has received FDA 510(k) clearance for the POWERSEAL Open Extended Jaw Sealer/Divider. This latest edition to the Olympus POWERSEAL advanced bipolar surgical energy portfolio supports clinical needs for precision, efficiency and control during surgery. POWERSEAL Open Extended Jaw Sealer/Divider The POWERSEAL Open Extended Jaw Sealer/Divider joins three 5mm devices in the POWERSEAL portfolio. These 5mm devices are offered in three jaw configurations, each av

Johnson & Johnson has received European CE Mark approval for its new ETHICON 4000 Stapler, an advanced surgical stapler designed to deliver reliable staple line integrity across a wide range of tissue thickness. ETHICON 4000 Stapler With proprietary 3D Stapling Technology, a redesigned end-effector and streamlined reload options, the ETHICON 4000 and ETHICON 3D Reloads are certified for use in open and laparoscopic surgery across the European Union. The new advanced stapling

Reach Surgical, the surgical solutions division of Genesis MedTech, has received CE Mark approval for iREACH IRIS, a next-generation powered stapling platform designed to deliver Real-Time Firing Curve and up to 90° articulation during surgery. iREACH IRIS Reusable Stapler with Real-Time Firing Curve™ and 90° Articulation Unlike conventional powered staplers that provide general firing feedback, iREACH IRIS Real-Time Firing Curve provides a continuous, location-specific force

The FDA has approved Eli Lilly and Company’s Foundayo (orforglipron) for adults with obesity or overweight with weight-related medical problems. Foundayo is a once-daily small molecule (non-peptide) oral glucagon-like peptide-1 receptor agonist (GLP-1ra) that can be taken any time of the day without restrictions on food and water intake. "People living with obesity need treatment options that meet them where they are – and for many, a once-daily pill that can be taken with n